Notice of Change in Reporting Requirements for The Federal Cigarette Labeling and Advertising Act (FCLAA) and Comprehensive Smokeless Tobacco Health Education Act (CSTHEA), 23359-23360 [2020-08797]
Download as PDF
<![CDATA[
23359
Federal Register / Vol. 85, No. 81 / Monday, April 27, 2020 / Notices
department of the four hospital sites
with febrile illness, and will be
interviewed to gather information on
symptoms, possible exposures, and
medical history, in addition to having
diagnostic samples collected to test for
leptospirosis plus or minus melioidosis
(depending on presenting symptoms).
reservoirs related to human
leptospirosis illness in Puerto Rico.
The estimated annualized burden
hours requested are 1,675. There is no
cost to respondents other than their
time.
Participants will then also be
interviewed approximately two weeks
after enrollment to determine illness
progression and outcome. Patients
testing positive for leptospirosis, if
willing, may have animals sampled
from their home or work environments,
if present, to help determine the animal
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Patient
Patient
Patient
Patient
Patient
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
...............................................
...............................................
...............................................
...............................................
...............................................
PIFA (screening) ..............................
PIFA (full form: Sections 1–4, 11) ...
Consent Form ..................................
PIFF ..................................................
Animal Household Survey ................
7,000
3,000
3,000
1,000
250
1
1
1
1
1
5/60
10/60
6/60
10/60
30/60
583
500
300
167
125
Total ...........................................
...........................................................
........................
........................
........................
1,675
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–08794 Filed 4–24–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
lotter on DSKBCFDHB2PROD with NOTICES
Number of
respondents
Form name
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
CE15–002: The CDC National Centers of
Excellence in Youth Violence
Prevention: Building the Evidence for
Community- and Policy-Level
Prevention.
VerDate Sep<11>2014
17:32 Apr 24, 2020
Jkt 250001
Date: June 17, 2020.
Time: 8:30 a.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Mikel Walters, Ph.D., Scientific Review
Official, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop F–63, Atlanta,
Georgia 30341, Telephone (404)639–
0913, MWalters@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–08808 Filed 4–24–20; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Change in Reporting
Requirements for The Federal
Cigarette Labeling and Advertising Act
(FCLAA) and Comprehensive
Smokeless Tobacco Health Education
Act (CSTHEA)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces that
it is extending the March 31, 2020
deadline for submissions required under
the Federal Cigarette Labeling and
Advertising Act (FCLAA) and the
Comprehensive Smokeless Tobacco
Health Education Act (CSTHEA) for
cigarette and smokeless tobacco
products, respectively. CDC also
announces that it is extending the
deadline for ingredient reports for new
products that are due at the time of first
importation. Previous notices
announced that ingredient reports are
due annually on March 31, and/or upon
initial importation of cigarettes and/or
smokeless tobacco products. Due to the
current public health response to
COVID–19, CDC is not able to accept
any ingredient submissions and will not
be issuing Certificates of Compliance at
this time. CDC is communicating this
information to state government entities
and will re-evaluate this approach as
necessary.
SUMMARY:
E:\FR\FM\27APN1.SGM
27APN1
23360
Federal Register / Vol. 85, No. 81 / Monday, April 27, 2020 / Notices
FOR FURTHER INFORMATION CONTACT:
Kathy Gallagher, Associate Director for
Policy, the Office on Smoking and
Health, the Centers for Disease Control
and Prevention, 4770 Buford Highway
NE, Chamblee, Georgia 30341;
nccdoshfclaa@cdc.gov or at 404–639–
5349.
The
Paperwork Reduction Act (PRA)requires
that Federal agencies obtain approval
from the Office of Management and
Budget (OMB) for the standardized
collection of data from 10 or more
entities. CDC has approval from OMB
under Control Number 0920–0210,
which expires April 30, 2022, to collect
cigarette ingredient information.
Pursuant to FCLAA, each manufacturer,
packager, or importer of cigarettes must
annually submit to HHS a list of
ingredients added to tobacco in the
manufacture of cigarettes. CDC has been
delegated by HHS with the
responsibility of implementing
provisions under FCLAA. Submissions
of reports are due to CDC every year by
March 31, and/or upon initial
importation of tobacco products into the
United States.
CDC also has approval from OMB
under Control Number 0920–0338,
which expires April 30, 2022, to collect
smokeless tobacco product ingredient
and nicotine content information.
Pursuant to the CSTHEA, each
manufacturer, packager, or importer of
smokeless tobacco products must
annually submit to HHS a list of
ingredients added to tobacco in the
manufacture of smokeless tobacco
products and the quantity of nicotine
contained in each smokeless tobacco
product. CDC has been delegated by
HHS with the responsibility of
implementing provisions under
CSTHEA. Submissions of reports are
due to CDC every year by March 31,
and/or upon initial importation of
smokeless tobacco products.
Upon receipt of reports pursuant to
FCLAA and CSTHEA, CDC issued
Certificates of Compliance for all
submissions that met the following
requirements: (1) The submission
clearly states on whose behalf the
submission is made; and (2) the list of
ingredients, including chemical names
and corresponding Chemical Abstract
Service (CAS) registry numbers, added
to tobacco in the manufacture of
cigarettes and/or smokeless tobacco
products is complete and without error.
Due to the current COVID–19 public
health crisis, CDC is indefinitely
extending the March 31, 2020 deadline.
CDC is neither processing any
previously received reports nor issuing
lotter on DSKBCFDHB2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:32 Apr 24, 2020
Jkt 250001
Certificates of Compliance at this time.
CDC will provide updates to the public
through subsequent notices published
in the Federal Register.
Dated: April 21, 2020.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2020–08797 Filed 4–24–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–20–20MT; Docket No. CDC–2020–
0040]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled The National Firefighter Registry
(NFR). In accordance with the
Firefighter Cancer Registry Act of 2018,
the National Firefighter Registry (NFR)
will develop and maintain a voluntary
registry of firefighters to collect relevant
health and occupational information of
such firefighters for purposes of
determining cancer incidence.
DATES: CDC must receive written
comments on or before June 26, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0040 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
The National Firefighter Registry—
New—National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
E:\FR\FM\27APN1.SGM
27APN1
]]>Agencies
[Federal Register Volume 85, Number 81 (Monday, April 27, 2020)]
[Notices]
[Pages 23359-23360]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08797]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Change in Reporting Requirements for The Federal
Cigarette Labeling and Advertising Act (FCLAA) and Comprehensive
Smokeless Tobacco Health Education Act (CSTHEA)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces
that it is extending the March 31, 2020 deadline for submissions
required under the Federal Cigarette Labeling and Advertising Act
(FCLAA) and the Comprehensive Smokeless Tobacco Health Education Act
(CSTHEA) for cigarette and smokeless tobacco products, respectively.
CDC also announces that it is extending the deadline for ingredient
reports for new products that are due at the time of first importation.
Previous notices announced that ingredient reports are due annually on
March 31, and/or upon initial importation of cigarettes and/or
smokeless tobacco products. Due to the current public health response
to COVID-19, CDC is not able to accept any ingredient submissions and
will not be issuing Certificates of Compliance at this time. CDC is
communicating this information to state government entities and will
re-evaluate this approach as necessary.
[[Page 23360]]
FOR FURTHER INFORMATION CONTACT: Kathy Gallagher, Associate Director
for Policy, the Office on Smoking and Health, the Centers for Disease
Control and Prevention, 4770 Buford Highway NE, Chamblee, Georgia
30341; [email protected] or at 404-639-5349.
SUPPLEMENTARY INFORMATION: The Paperwork Reduction Act (PRA)requires
that Federal agencies obtain approval from the Office of Management and
Budget (OMB) for the standardized collection of data from 10 or more
entities. CDC has approval from OMB under Control Number 0920-0210,
which expires April 30, 2022, to collect cigarette ingredient
information. Pursuant to FCLAA, each manufacturer, packager, or
importer of cigarettes must annually submit to HHS a list of
ingredients added to tobacco in the manufacture of cigarettes. CDC has
been delegated by HHS with the responsibility of implementing
provisions under FCLAA. Submissions of reports are due to CDC every
year by March 31, and/or upon initial importation of tobacco products
into the United States.
CDC also has approval from OMB under Control Number 0920-0338,
which expires April 30, 2022, to collect smokeless tobacco product
ingredient and nicotine content information. Pursuant to the CSTHEA,
each manufacturer, packager, or importer of smokeless tobacco products
must annually submit to HHS a list of ingredients added to tobacco in
the manufacture of smokeless tobacco products and the quantity of
nicotine contained in each smokeless tobacco product. CDC has been
delegated by HHS with the responsibility of implementing provisions
under CSTHEA. Submissions of reports are due to CDC every year by March
31, and/or upon initial importation of smokeless tobacco products.
Upon receipt of reports pursuant to FCLAA and CSTHEA, CDC issued
Certificates of Compliance for all submissions that met the following
requirements: (1) The submission clearly states on whose behalf the
submission is made; and (2) the list of ingredients, including chemical
names and corresponding Chemical Abstract Service (CAS) registry
numbers, added to tobacco in the manufacture of cigarettes and/or
smokeless tobacco products is complete and without error.
Due to the current COVID-19 public health crisis, CDC is
indefinitely extending the March 31, 2020 deadline. CDC is neither
processing any previously received reports nor issuing Certificates of
Compliance at this time. CDC will provide updates to the public through
subsequent notices published in the Federal Register.
Dated: April 21, 2020.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2020-08797 Filed 4-24-20; 8:45 am]
BILLING CODE 4163-18-P
